Skip to main content
Article thumbnail
Location of Repository

T lymphocyte Recruitment to the Lung in Asthma

By Kugathasan Mutalithas

Abstract

T cells play an important part in the pathogenesis of asthma. In this study greater numbers of T cells were seen in the bronchial epithelium of severe asthmatics compared to normal subjects. There were greater percentages of both IL-4+ and IFN-γ+ T cells in the bronchoalveolar lavage of asthmatics compared to normal subjects. Chemokines and their receptors are thought to act as signals that guide particular subsets of T cells to the lung in asthma. Using flow cytometry I had explored whether the chemokine receptors CCR8 and CRTh2 played any role in recruiting T cells and in particular IL-4+ T cells to the lung in asthma. Both receptors selectively identified IL-4+ and IL-13+ T cells in the blood and bronchoalveolar lavage from asthmatics and normal subjects. Cells expressing CCR8 but not CRTh2 were found at a higher percentage in the blood of severe asthmatics compared to normal controls. The percentage of CCR8+ T in the bronchoalveolar lavage of asthmatics was higher compared to normal subjects and furthermore, there was a greater percentage of CCR8+ T cells in the bronchoalveolar lavage compared to blood within the same asthmatic subject. This difference in the percentage of CCR8+ T cells between blood and BAL was not seen in normal subjects. This suggests that there may be a role for CCR8 in the recruitment of T cells to the lung in asthma. In support of this, higher concentrations of the ligand CCL1, were seen in the bronchoalveolar lavage of asthmatics compared to that from normal subjects. Little experimental evidence was found that supported the contention that CRTh2 played a significant role in T cell recruitment to the lung. As a marker of IL-4+ T cells in asthmatics, CCR8 compared favourably with CRTh2 as they identified a greater percentage of IL-4+ T cells in bronchoalveolar lavage than CRTh2. CCR8 also compared favourably with CCR4 as a marker for IL-4+ T cells due to higher specificity. The iNKT subset of T cells has been claimed to be an important group of T cells in asthma and was reported to be present at high percentages in the lung of moderate to severe asthmatics. In this study we had shown that in asthmatics these cells are present in very low percentages, similar to that in normal subjects and that they probably do not play a significant role in severe asthma

Publisher: University of Leicester
Year: 2009
OAI identifier: oai:lra.le.ac.uk:2381/9545

Suggested articles

Citations

  1. (2005). A centennial history of research on asthma pathogenesis.
  2. (2006). A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants. Immunology,
  3. (2000). A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum. J Exp Med,
  4. (2000). A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J Exp Med,
  5. (1989). A novel polypeptide secreted by activated human T lymphocytes.
  6. (2006). A role for natural killer T cells in asthma. Nat Rev Immunol,
  7. Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice.
  8. (2003). Absence of CCR8 does not impair the response to ovalbumininduced allergic airway disease.
  9. (1993). Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol,
  10. (2005). Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse.
  11. (2002). Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice. Faseb J,
  12. (1998). Airway inflammation in mild intermittent and in persistent asthma.
  13. (2004). Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med,
  14. (1999). Allergen-specific Th1 cells fail to counterbalance Th2 cellinduced airway hyperreactivity but cause severe airway inflammation.
  15. (1992). Allergic and nonallergic asthmatics have distinct patterns of Tcell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis,
  16. (1996). Alveolar tissue inflammation in asthma.
  17. (2002). AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity.
  18. (2003). An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J Pharmacol Exp Ther,
  19. (2007). Animal models of asthma. Clin Exp Allergy,
  20. (2007). Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat Rev Drug Discov,
  21. (2005). Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma.
  22. (2000). Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma. Am J Respir Crit Care Med,
  23. (2002). Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet,
  24. (2001). Asthma, atopy, and IgE: what is the link? Curr Allergy Asthma Rep,
  25. (2004). Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome.
  26. (1994). Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways.
  27. (1998). Bronchial neutrophilia in patients with noninfectious status asthmaticus.
  28. (2007). Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma.
  29. (1997). Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med,
  30. (2000). CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation,
  31. (2006). CC chemokine ligand 1 is released into the airways of atopic asthmatics. Eur Respir J,
  32. (2003). CC chemokine ligand 1 promotes recruitment of eosinophils but not Th2 cells during the development of allergic airways disease.
  33. (2000). CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med,
  34. (2000). CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment.
  35. (2005). CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
  36. (2002). CCR4 in human allergen-induced late responses in the skin and lung.
  37. (2006). CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes.
  38. (2003). CCR8 is not essential for the development of inflammation in a mouse model of allergic airway disease.
  39. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis,
  40. (2006). CD4+ Invariant T-Cell-Receptor+ Natural Killer T cells in Bronchial Asthma.
  41. (2005). Chemokine control of lymphocyte trafficking: a general overview. Immunology,
  42. (2004). Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy,
  43. (2001). Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.
  44. (2004). Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion.
  45. (1999). Chemokine receptors and other surface molecules preferentially associated with human
  46. (2005). Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients. Clin Exp Allergy,
  47. (1999). Chemokines and asthma: redundancy of function or a coordinated effort? J Clin Invest,
  48. (2000). Chemokines and their role in airway hyper-reactivity. Respir Res,
  49. (2003). Chemokines in allergic airway disease. Curr Opin Pharmacol,
  50. (2003). Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol,
  51. (1998). Chemokines--chemotactic cytokines that mediate inflammation.
  52. (2000). Chemokines: a new classification system and their role in immunity. Immunity,
  53. Chemokines: immunology's high impact factors. Nat Immunol,
  54. (2007). Chronic antigen stimulation in vivo induces a distinct population of antigen-specific
  55. (2004). Circulating natural killer T cells in patients with asthma.
  56. (1998). Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia.
  57. (1996). Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
  58. (2008). Cluster analysis and clinical asthma phenotypes.
  59. (1993). Combination IL-2 and IL-4 reduces glucocorticoid receptorbinding affinity and T cell response to glucocorticoids.
  60. (2003). Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax,
  61. (1992). Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies. Am Rev Respir Dis,
  62. (2007). Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis.
  63. (2000). CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease.
  64. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s).
  65. (2005). Cutting edge: chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil
  66. (2003). Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model.
  67. (2002). Cutting edge: Th2 cell trafficking into the allergic lung is dependent on chemoattractant receptor signaling.
  68. (2002). Cytokine coexpression during human Th1/Th2 cell differentiation: Direct evidence for coordinated expression of Th2 cytokines.
  69. (2001). Cytokine profile of bronchoalveolar lavage-derived CD4(+), CD8(+), and gammadelta T cells in people with asthma after segmental allergen challenge.
  70. Decrease of interleukin-10-producing T cells in the peripheral blood of severe unstable atopic asthmatics. Int Arch Allergy Immunol,
  71. (1994). Depletion of murine CD4+ T lymphocytes prevents antigeninduced airway hyperreactivity and pulmonary eosinophilia.
  72. Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).
  73. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.
  74. (1997). Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration.
  75. (1997). Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med,
  76. (1994). Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites.
  77. (1998). Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma.
  78. (1997). Does the mast cell still have a key role in asthma? Chest,
  79. (2000). Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet,
  80. (2000). Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet,
  81. (1993). Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis,
  82. (2001). Enhanced airway Th2 response after allergen challenge in mice deficient
  83. (1997). Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant colocalization of eotaxin mRNA to bronchial epithelial and endothelial cells.
  84. Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma.
  85. (2001). Eosinophils in asthma and other allergic diseases.
  86. (2003). Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway
  87. (1990). Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients.
  88. (2001). Expression of chemokine receptors by lung T cells from normal and asthmatic subjects.
  89. (2005). Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy,
  90. (1997). Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol,
  91. (1994). Expression of multiple chemokine genes by a human mast cell leukemia.
  92. (1998). Flexible programs of chemokine receptor expression on human polarized
  93. (1998). Frequencies of T cells expressing interleukin-4 and interleukin-5 in atopic asthmatic children. Comparison with atopic asthmatic adults. Am J Respir Crit Care Med,
  94. (2000). From bronchoconstriction to airways inflammation and remodeling.
  95. (1999). Gene expression of the GATA-3 transcription factor is increased in atopic asthma.
  96. (2000). Glucocorticoids in T cell development and function*. Annu Rev Immunol,
  97. (2004). Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma.
  98. (2006). Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells.
  99. (2003). Homing and cellular traffic in lymph nodes. Nat Rev Immunol,
  100. (1998). How do lymphocytes get into the asthmatic airways? Lymphocyte traffic into and within the lung in asthma. Clin Exp Allergy,
  101. (2008). How regulatory T cells work. Nat Rev Immunol,
  102. (2001). Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood,
  103. (2003). Human cord blood-derived mast cells synthesize and release I-309 in response to IgE. Life Sci,
  104. (2000). Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J Immunol,
  105. (2000). I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood,
  106. (1996). I-309/T cell activation gene-3 chemokine protects murine T cell lymphomas against dexamethasone-induced apoptosis.
  107. (1997). Identification of CCR8, the receptor for the human CC chemokine I-309.
  108. (1997). Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J Exp Med,
  109. (1992). Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis,
  110. (1998). Identification of the CC chemokines TARC and macrophage inflammatory protein-1 beta as novel functional ligands for the CCR8 receptor.
  111. (1996). IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med,
  112. (2005). IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express
  113. (1998). IL-4-independent induction of airway hyperresponsiveness by
  114. (1999). Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med,
  115. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.
  116. (1995). In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with air flow limitation: in vivo evidence of VCAM-1/VLA-4 interaction in selective eosinophil infiltration.
  117. (1996). Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma.
  118. (2001). Increased expression of the chemoattractant cytokines eotaxin, monocyte chemotactic protein-4, and interleukin-16 in induced sputum in asthmatic patients. Chest,
  119. (2002). Increased responsiveness of murine eosinophils to MIP1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors,
  120. (1993). Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colonystimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics.
  121. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells.
  122. (1997). Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med,
  123. (1998). Induction of pulmonary allergic responses by antigen-specific Th2 cells.
  124. (2000). Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma.
  125. (1999). Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity,
  126. (1996). Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.
  127. (1994). Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines.
  128. (1998). Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med,
  129. (2001). Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice.
  130. (2007). Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease.
  131. (2006). Invariant natural killer T cells in bronchial asthma.
  132. (2001). Is asthma really due to a polarized T cell response toward a helper T cell type 2 phenotype? Am J Respir Crit Care Med,
  133. (2006). Leukocyte navigation mechanisms as targets in airway diseases. Drug Discov Today,
  134. (2000). Leukocyte trafficking in alveoli and airway passages. Respir Res,
  135. (2004). Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol,
  136. (1999). Long-term clinical efficacy of grass-pollen immunotherapy.
  137. Lymphocyte homing and homeostasis.
  138. (1976). Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for highendothelial venules. J Exp Med,
  139. (1999). Lymphocyte trafficking and regional immunity. Adv Immunol,
  140. (2000). Lymphocytes migrate from the blood into the bronchoalveolar lavage and lung parenchyma in the asthma model of the brown Norway rat. Am J Respir Crit Care Med,
  141. (2002). Mast cell infiltration of airway smooth muscle in asthma.
  142. (2002). Mast-cell infiltration of airway smooth muscle in asthma.
  143. (2005). Mechanisms of T cell migration to the lung. Clin Exp Allergy,
  144. (2006). Memory T cell populations in the lung airways are maintained by continual recruitment.
  145. (2006). Memory T cell recruitment to the lung airways. Curr Opin Immunol,
  146. (2001). Migration of T Cells In Vivo: Molecular Mechanisms and Clinical Implications. Ann Intern Med,
  147. (1991). Monocyte chemoattractant protein-1 in human atheromatous plaques.
  148. (1999). Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation.
  149. (1997). Multistep navigation and the combinatorial control of leukocyte chemotaxis.
  150. (2005). Natural killer T cells: rapid responders controlling immunity and disease.
  151. (2004). Naturally arising CD4+ regulatory t cells for immunologic selftolerance and negative control of immune responses. Annu Rev Immunol,
  152. (2000). Non-redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lung. Immunol Rev,
  153. (1985). Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease.
  154. (2007). Oxazolidinones as novel human CCR8 antagonists. Bioorg Med Chem Lett,
  155. Peripheral blood CD4+ and CD8+ T cell type 1 and type 2 cytokine production in atopic asthmatic and normal subjects. Clin Exp Allergy,
  156. (1993). Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am Rev Respir Dis,
  157. (1991). Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen.
  158. (1992). Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.
  159. (2005). Prevalence of asthma. Bmj,
  160. (2005). Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response.
  161. (2005). Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on
  162. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.
  163. (2006). Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor.
  164. (2001). Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med,
  165. (2005). Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J Pharmacol Exp Ther,
  166. (1999). Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.
  167. Receptor-mediated endocytosis of CC-chemokines.
  168. (1997). Recruitment of circulating allergen-specific T lymphocytes to the lung on allergen challenge in asthma. J Allergy Clin Immunol,
  169. (1999). Regulation of lymphocyte traffic by adhesion molecules. Inflamm Res,
  170. (2003). Regulatory T cells control the development of allergic disease and asthma.
  171. (2001). Regulatory T cells in the control of immune pathology. Nat Immunol,
  172. (2000). Regulatory T cells: key controllers of immunologic self-tolerance.
  173. (2005). Regulatory T-lymphocytes in asthma. Eur Respir J,
  174. (2004). Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet,
  175. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma.
  176. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions.
  177. (2007). Remission of chronic fungal asthma in the absence of CCR8. J Allergy Clin Immunol,
  178. (2007). Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma.
  179. (1998). Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med,
  180. (2001). Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol,
  181. Role of interleukin 10 in specific immunotherapy.
  182. (1992). Role of type 1 and type 2 T helper cells in allergic diseases. Curr Opin Immunol,
  183. (2001). Rules of chemokine receptor association with T cell polarization in vivo.
  184. (1995). Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls.
  185. (2004). Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol,
  186. (1999). Selective expression of a novel surface molecule by human
  187. (1997). Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science,
  188. (2001). Selective modulation of chemokinesis, degranulation, and apoptosis
  189. (1998). Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells.
  190. Sequence and chromosomal location of the I-309 gene. Relationship to genes encoding a family of inflammatory cytokines.
  191. (2004). Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability. Hum Mol Genet,
  192. (2007). Severe asthma: lessons from the Severe Asthma Research Program.
  193. (1995). T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma.
  194. (1992). T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis,
  195. (1996). T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma.
  196. (2000). T-cell function and migration. Two sides of the same coin.
  197. (2003). T-cell integrins: more than just sticking points.
  198. (2001). T-cell responses in allergy and asthma. Curr Opin Allergy Clin Immunol,
  199. (2000). Targeting cytokines in asthma therapy: round one. Lancet,
  200. (2000). Th-2 cytokines in allergic disease. Br Med Bull,
  201. (2002). TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J Allergy Clin Immunol,
  202. (1999). The assignment of chemokine-chemokine receptor pairs: TARC and MIP-1 beta are not ligands for human CC-chemokine receptor 8. Eur J Immunol,
  203. (2000). The biology of chemokines and their receptors. Annu Rev Immunol,
  204. (2007). The biology of NKT cells. Annu Rev Immunol,
  205. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics.
  206. (1998). The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains.
  207. (1998). The chemokine receptor CCR8 is preferentially expressed in
  208. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness.
  209. (2005). The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med,
  210. (2001). The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma. Eur Respir J,
  211. (1999). The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. Am J Respir Crit Care Med,
  212. (2004). The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy,
  213. (2008). The highway code of T cell trafficking.
  214. (1992). The human cytokine I-309 is a monocyte chemoattractant.
  215. The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients.
  216. The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot Essent Fatty Acids,
  217. (1998). The Th1/Th2 paradigm and allergic disorders. Allergy,
  218. (2004). Tregs and allergic disease.
  219. (1999). Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature,
  220. (1996). u3405, a thromboxane A2 antagonist, reduces bronchial hyperresponsiveness in asthmatics. Chest,
  221. (2001). Unique chemotactic response profile and specific expression of chemokine receptors
  222. (2001). Variant eotaxin: its effects on the asthma phenotype.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.